What Researchers Did
Researchers conducted a randomized controlled trial with 103 participants to investigate the effect of hyperbaric oxygen therapy on health-related quality of life in individuals with diabetic foot ulcers.
What They Found
No significant differences in overall health-related quality of life, measured by EQ-5D index values, were observed between the hyperbaric oxygen therapy and sham groups at week 6 (0.07, p=0.64) or week 12 (0.01, p=0.93). However, hyperbaric oxygen therapy was associated with fewer participants reporting problems in mobility (OR 0.24 at week 12) and pain or discomfort (OR 0.20 at week 6; OR 0.32 at week 12).
What This Means for Canadian Patients
Hyperbaric oxygen therapy might offer some relief for specific symptoms like mobility and pain in Canadian patients with diabetic foot ulcers. However, it did not show a significant overall improvement in their general quality of life.
Canadian Relevance
This study, involving Canadian researchers, addresses a health issue prevalent in Canada, where diabetes and its complications like foot ulcers are a significant concern.
Study Limitations
The study's primary outcome showed no significant difference, and the abstract alludes to potential insufficiencies, possibly related to power or the specific quality of life measures used.